Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Antimicrob Agents Chemother ; 45(5): 1589-90, 2001 May.
Artigo em Inglês | MEDLINE | ID: mdl-11302836

RESUMO

Susceptibility of strain S288c of Saccharomyces cerevisiae to fluconazole was assayed in the presence and absence of KCl. Addition of 150 mM KCl renders the strain more sensitive to the antifungal agent. The effect is caused by the K(+) ion rather than the anion or the osmolarity of the medium. The increase in sensitivity does not modify the values of intracellular and extracellular pH established in the presence of KCl.


Assuntos
Antifúngicos/farmacologia , Fluconazol/farmacologia , Cloreto de Potássio/farmacologia , Saccharomyces cerevisiae/efeitos dos fármacos , Contagem de Colônia Microbiana , Interações Medicamentosas , Resistência Microbiana a Medicamentos , Concentração de Íons de Hidrogênio , Testes de Sensibilidade Microbiana
2.
Rev Argent Microbiol ; 32(3): 157-60, 2000.
Artigo em Espanhol | MEDLINE | ID: mdl-11008709

RESUMO

Severe mycotic infections are a source of concern in immunocompromised patients or in those who receive chemotherapy for hematological malignant diseases. One of the causes is referred to the appearance of antimycotic resistant microorganisms. Fluconazole is one of the antimycotic used for invasive mycoses treatment. Therefore it is necessary to evaluate the factors that originate this resistance. In the present report the yeast Saccharomyces cerevisiae S288c was used as a model system. In resistant strains the accumulation of the lipophilic cation Rhodamine 6G, L-leucine uptake and growth inhibition by crystal violet dye were determined. The results presented herein demonstrate the correlation between the membrane potential and the resistance to fluconazole presented by S. cerevisiae strain S288c.


Assuntos
Antifúngicos/farmacologia , Resistência Microbiana a Medicamentos , Fluconazol/farmacologia , Potenciais da Membrana/efeitos dos fármacos , Rodaminas/metabolismo , Saccharomyces cerevisiae/metabolismo , Antifúngicos/metabolismo , Meios de Cultura/farmacologia , Fluconazol/metabolismo , Violeta Genciana/metabolismo , Violeta Genciana/farmacologia , Leucina/metabolismo , Lipídeos de Membrana/metabolismo , Prolina/farmacologia , Saccharomyces cerevisiae/efeitos dos fármacos , Saccharomyces cerevisiae/crescimento & desenvolvimento , Esteróis/metabolismo
3.
Rev. argent. microbiol ; 32(3): 157-160, jul.-sept. 2000.
Artigo em Espanhol | LILACS | ID: lil-332520

RESUMO

Severe mycotic infections are a source of concern in immunocompromised patients or in those who receive chemotherapy for hematological malignant diseases. One of the causes is referred to the appearance of antimycotic resistant microorganisms. Fluconazole is one of the antimycotic used for invasive mycoses treatment. Therefore it is necessary to evaluate the factors that originate this resistance. In the present report the yeast Saccharomyces cerevisiae S288c was used as a model system. In resistant strains the accumulation of the lipophilic cation Rhodamine 6G, L-leucine uptake and growth inhibition by crystal violet dye were determined. The results presented herein demonstrate the correlation between the membrane potential and the resistance to fluconazole presented by S. cerevisiae strain S288c.


Assuntos
Antifúngicos/farmacologia , Fluconazol , Potenciais da Membrana , Resistência Microbiana a Medicamentos , Rodaminas , Saccharomyces cerevisiae , Antifúngicos/metabolismo , Meios de Cultura , Esteróis/metabolismo , Fluconazol , Violeta Genciana , Leucina , Lipídeos de Membrana/metabolismo , Prolina , Saccharomyces cerevisiae
4.
Rev. argent. microbiol ; 32(3): 157-160, jul.-sept. 2000.
Artigo em Espanhol | BINACIS | ID: bin-6733

RESUMO

Severe mycotic infections are a source of concern in immunocompromised patients or in those who receive chemotherapy for hematological malignant diseases. One of the causes is referred to the appearance of antimycotic resistant microorganisms. Fluconazole is one of the antimycotic used for invasive mycoses treatment. Therefore it is necessary to evaluate the factors that originate this resistance. In the present report the yeast Saccharomyces cerevisiae S288c was used as a model system. In resistant strains the accumulation of the lipophilic cation Rhodamine 6G, L-leucine uptake and growth inhibition by crystal violet dye were determined. The results presented herein demonstrate the correlation between the membrane potential and the resistance to fluconazole presented by S. cerevisiae strain S288c.(AU)


Assuntos
Estudo Comparativo , Antifúngicos/farmacologia , Resistência Microbiana a Medicamentos , Fluconazol/farmacologia , Potenciais da Membrana/efeitos dos fármacos , Rodaminas/metabolismo , Saccharomyces cerevisiae/metabolismo , Antifúngicos/metabolismo , Meios de Cultura/farmacologia , Fluconazol/metabolismo , Violeta Genciana/metabolismo , Violeta Genciana/farmacologia , Leucina/metabolismo , Lipídeos de Membrana/metabolismo , Prolina/farmacologia , Saccharomyces cerevisiae/efeitos dos fármacos , Saccharomyces cerevisiae/crescimento & desenvolvimento , Esteróis/metabolismo
5.
Rev. argent. microbiol ; 32(3): 157-60, 2000 Jul-Sep.
Artigo em Espanhol | BINACIS | ID: bin-39788

RESUMO

Severe mycotic infections are a source of concern in immunocompromised patients or in those who receive chemotherapy for hematological malignant diseases. One of the causes is referred to the appearance of antimycotic resistant microorganisms. Fluconazole is one of the antimycotic used for invasive mycoses treatment. Therefore it is necessary to evaluate the factors that originate this resistance. In the present report the yeast Saccharomyces cerevisiae S288c was used as a model system. In resistant strains the accumulation of the lipophilic cation Rhodamine 6G, L-leucine uptake and growth inhibition by crystal violet dye were determined. The results presented herein demonstrate the correlation between the membrane potential and the resistance to fluconazole presented by S. cerevisiae strain S288c.

6.
Folia Microbiol (Praha) ; 43(4): 403-5, 1998.
Artigo em Inglês | MEDLINE | ID: mdl-9821294

RESUMO

Fluconazole inhibition of Saccharomyces cerevisiae S288c growth was evaluated in media containing ammonia, L-proline or L-leucine as a nitrogen source. Growth inhibition by fluconazole was maximum when L-proline was used as a nitrogen source, while rhodamine 6G accumulation and fluconazole resistance were the highest when ammonia was the sole nitrogen source.


Assuntos
Antifúngicos/farmacologia , Fluconazol/farmacologia , Nitrogênio/metabolismo , Prolina/metabolismo , Saccharomyces cerevisiae/efeitos dos fármacos , Meios de Cultura , Resistência Microbiana a Medicamentos , Testes de Sensibilidade Microbiana , Rodaminas/metabolismo , Saccharomyces cerevisiae/crescimento & desenvolvimento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...